Pharma: Clinic Roundup
Upsher-Smith Laboratories Inc., of Maple Grove, Minn., completed a global Phase III trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults.
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Sign up for Perspectives FREE e-mail newsletter